Management and Prognosis of Acute Stroke in Atrial Fibrillation-Reference-Cited by-同舟云学术

Management and Prognosis of Acute Stroke in Atrial Fibrillation

Published:2023-09-04 Issue:17 Volume:12 Page:5752
ISSN:2077-0383
Container-title:Journal of Clinical Medicine
language:en
Short-container-title:JCM

Author:

Hindsholm Mette F.¹²^ORCID,Damgaard Dorte¹,Gurol M. Edip³⁴,Gaist David⁵^ORCID,Simonsen Claus Z.¹²

Affiliation:

1. Department of Neurology, Aarhus University Hospital, 8200 Aarhus, Denmark

2. Department of Clinical Medicine, Aarhus University, 8200 Aarhus, Denmark

3. Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA

4. Harvard Medical School, Boston, MA 02115, USA

5. Research Unit for Neurology, Odense University Hospital, University of Southern Denmark, 5000 Odense, Denmark

Abstract

Atrial fibrillation (AF) is an important risk factor for ischemic stroke (IS). Oral anticoagulation (OAC) significantly reduces the risk of IS in AF but also increases the risk of systemic bleeding, including intracerebral hemorrhage (ICH). AF-related strokes are associated with greater disability and mortality compared to non-AF strokes. The management of patients with AF-related strokes is challenging, and it involves weighing individual risks and benefits in the acute treatment and preventive strategies of these patients. This review summarizes the current knowledge of the acute management of ischemic and hemorrhagic stroke in patients with AF, and the prognosis and potential implications for management both in the acute and long-term setting.

Funder

C. B. Holding Århus ApS/Claus Brændstrup and wife

Publisher

MDPI AG

Subject

General Medicine

Link

https://www.mdpi.com/2077-0383/12/17/5752/pdf

Reference157 articles.

1. World Stroke Organization (WSO) (2023, April 18). Global Stroke Fact Sheet 2022.pdf. Available online: https://www.dropbox.com/s/wm12nosylzkk5ea/World%20Stroke%20Organization%20%28WSO%29-%20Global%20Stroke%20Fact%20Sheet%202022.pdf?dl=0.

2. The Future of Atrial Fibrillation Management: Integrated Care and Stratified Therapy;Kirchhof;Lancet,2017

3. Stroke Prevention in Atrial Fibrillation;Freedman;Lancet,2016

4. 2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation Developed in Collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the Diagnosis and Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Developed with the Special Contribution of the European Heart Rhythm Association (EHRA) of the ESC;Hindricks;Eur. Heart J.,2021

5. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons;January;Circulation,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of warfarin, rivaroxaban, and dabigatran for effectiveness and safety in atrial fibrillation patients with different CHA2DS2-VASc scores: a retrospective cohort study;BMC Cardiovascular Disorders;2024-07-16

2. Interplay between polygenic variants related immune response and lifestyle factors mitigate the chances of stroke in a genome-wide association study;British Journal of Nutrition;2024-02-20

3. Stroke in Patients with Atrial Fibrillation: Epidemiology, Screening, and Prognosis;Journal of Clinical Medicine;2023-12-20

4. Prevalence and Impact of Cerebral Microbleeds on Clinical and Safety Outcomes in Acute Ischaemic Stroke Patients Receiving Reperfusion Therapy: A Systematic Review and Meta-Analysis;Biomedicines;2023-10-23